Literature DB >> 2662219

Serotonin receptor blocking effect of SCH 23390.

M Bijak1, A Smiałowski.   

Abstract

The effect of SCH 23390 administration on the serotonin system-dependent head twitch behavior was studied in the rat. A small dose of SCH 23390 (1.25 micrograms/kg), injected 20 min before the test, decreased the number of quipazine-induced head twitches. Repeated treatment with SCH 23390 (0.5 mg/kg, SC), once a day for 18 days, increased the number of spontaneously occurring and quipazine-induced head twitches. The enhancing effect of repeated administration of SCH 23390 was blocked by cyproheptadine (0.4 mg/kg). The results indicate that acute injection of SCH 23390 blocks central serotonin receptors, whereas repeated treatment induces their functional supersensitivity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2662219     DOI: 10.1016/0091-3057(89)90001-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists.

Authors:  T S Shippenberg; R Bals-Kubik; A Huber; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Administration of the D1-like dopamine receptor antagonist SCH-23390 into the medial nucleus accumbens shell attenuates cocaine priming-induced reinstatement of drug-seeking behavior in rats.

Authors:  Sharon M Anderson; Ausaf A Bari; R Christopher Pierce
Journal:  Psychopharmacology (Berl)       Date:  2002-12-19       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.